Multiple Myeloma Hub
Podcast készítő Scientific Education Support
57 Epizód
-
How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease
Közzétéve: 2020. 07. 08. -
Melphalan flufenamide (melflufen) + novel agents for RRMM
Közzétéve: 2020. 07. 08. -
Isatuximab plus KRd for high-risk NDMM
Közzétéve: 2020. 06. 24. -
Novel approaches in multiple myeloma: what is unique about CELMoDs?
Közzétéve: 2020. 06. 24. -
Hot topics in MM: quadruplets and anti-BCMA therapy
Közzétéve: 2020. 06. 24. -
Genomics of high-risk myeloma
Közzétéve: 2020. 06. 23. -
The association between the diversity of the oral microbiome and PFS
Közzétéve: 2020. 06. 22. -
Novel approaches in multiple myeloma: BFCR4350A
Közzétéve: 2020. 06. 18. -
Update from CARTITUDE-1 | What's new since ASH?
Közzétéve: 2020. 06. 08. -
Novel approaches in multiple myeloma: TAK-079
Közzétéve: 2020. 06. 04. -
Should we use KRd or VRd for patients with NDMM?
Közzétéve: 2020. 06. 04. -
What is the optimal treatment for bone lesions, including patients with renal insufficiency?
Közzétéve: 2020. 06. 03. -
Recent advances in our understanding of myeloma progression
Közzétéve: 2020. 06. 02. -
Quadruplet combinations in transplant-ineligible NDMM: isatuximab + Vd + cyclo or len
Közzétéve: 2020. 06. 01. -
How I treat elderly patients with NDMM
Közzétéve: 2020. 05. 28. -
Understanding resistance mechanisms to current standard of care and how to overcome them
Közzétéve: 2020. 05. 19. -
What is plasma cell leukemia and what are the latest advances in treatment?
Közzétéve: 2020. 05. 15.
Guided by an international Steering Committee of world experts in Multiple Myeloma (MM), the MM Hub is a global online resource providing key information on Multiple Myeloma for hematologists, oncologists and researchers, run in collaboration with the European School of Haematology (ESH). Our mission is to provide the latest global up-to-date clinical guidance in Multiple Myeloma, through a comprehensive coverage of evidence-based literature, drug approvals, case studies, expert opinions and international congress reports. Hosted on Acast. See acast.com/privacy for more information.
